[1]
A.Taher, M. et al. 2017. Rosiglitazone , Metformin or both for Treatment of Polycystic Ovary Syndrome. Iraqi Journal of Pharmaceutical Sciences . 17, 2 (Mar. 2017), 80–86. DOI:https://doi.org/10.31351/vol17iss2pp80-86.